文献速递乳腺乳腺X线

数字乳腺断层摄影与数字乳腺X线摄影检出早期乳腺癌按分级分层的比较:TOSYMA子分析

Digital Breast Tomosynthesis versus Digital Mammography for Detection of Early-Stage Cancers Stratified by Grade: A TOSYMA Subanalysis.
PubMed 文献 · Radiology · 2023-01-01

该研究为TOSYMA随机对照试验的探索性子分析,比较数字乳腺断层摄影联合合成乳腺X线摄影(DBT+SM)与数字乳腺X线摄影(DM)筛查检出的浸润性乳腺癌在分期、组织学分级、年龄和乳腺密度上的差异。结果显示DBT+SM组I期浸润性癌检出率高于DM组,尤其60-70岁致密乳腺女性中I期2或3级肿瘤检出率最高。

要点

  • DBT+SM组I期浸润性癌检出率为51.6/万(255/49462),DM组为30.0/万(149/49669)。
  • DBT+SM组I期2或3级肿瘤检出率33.7/万(166/49462),DM组21.3/万(106/49669)。
  • 60-70岁致密乳腺女性中DBT+SM组I期2或3级肿瘤检出率最高,为55.4/万(41/7364)。

核心结论

  • DBT+SM筛查似乎较DM筛查检出更多I期2或3级浸润性乳腺癌,在60-70岁致密乳腺女性中检出率最高。

研究设计与样本

  • TOSYMA研究为嵌入德国乳腺X线筛查计划的多中心随机对照试验,本分析为探索性子分析,2018年7月至2020年12月招募50-70岁女性,DBT+SM组49462例(中位年龄57岁[IQR 53-62岁]),DM组49669例(中位年龄57岁[IQR 53-62岁])。

诊断标准与关键数值

  • DBT+SM组I期肿瘤检出率51.6/万(255/49462),DM组30.0/万(149/49669)。
  • DBT+SM组I期2或3级肿瘤检出率33.7/万(166/49462),DM组21.3/万(106/49669),率差+12.3/万(95%CI 0.3-24.9),OR 1.6(95%CI 0.9-2.7)。
  • 60-70岁致密乳腺女性DBT+SM组I期2或3级肿瘤检出率55.4/万(41/7364),率差+21.6/万(95%CI -21.1-64.3),OR 1.6(95%CI 0.6-4.5)。

临床应用与阅片要点

  • 筛查报告中可关注DBT+SM对I期2或3级浸润性癌的检出优势,尤其60-70岁致密乳腺女性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Breast cancer screening with digital breast tomosynthesis (DBT) plus synthesized mammography (SM) increases invasive tumor detection compared with digital mammography (DM). However, it is not known how the prognostic characteristics of the cancers detected with the two screening approaches differ. Purpose To compare invasive breast cancers detected with DBT plus SM (test arm) versus DM (control arm) screening with regard to tumor stage, histologic grade, patient age, and breast density. Materials and Methods This exploratory subanalysis of the Tomosynthesis plus Synthesized Mammography (TOSYMA) study, which is a multicenter randomized controlled trial embedded in the German mammography screening program, recruited women aged 50-70 years from July 2018 to December 2020. It compared invasive cancer detection rates (iCDRs), rate differences, and odds ratios (ORs) between the arms stratified by Union for International Cancer Control (UICC) stage (I vs II-IV), histologic grade (1 vs 2 or 3), age group (50-59 vs 60-70 years), and Breast Imaging Reporting and Data System categories of breast density (A or B vs C or D). Results In total, 49 462 (median age, 57 years [IQR, 53-62 years]) and 49 669 (median age, 57 years [IQR, 53-62 years]) participants were allocated to DBT plus SM and DM screening, respectively. The iCDR of stage I tumors with DBT plus SM was 51.6 per 10 000 women (255 of 49 462) and with DM it was 30.0 per 10 000 women (149 of 49 669). DBT plus SM depicted more stage I tumors with grade 2 or 3 (166 of 49 462, 33.7 per 10 000 women) than DM (106 of 49 669, 21.3 per 10 000 women; rate difference, +12.3 per 10 000 women [95% CI: 0.3, 24.9]; OR, 1.6 [95% CI: 0.9, 2.7]). DBT plus SM achieved the highest iCDR of stage I tumors with grade 2 or 3 among women aged 60-70 years with dense breasts (41 of 7364, 55.4 per 10 000 women; rate difference, +21.6 per 10 000 women [95% CI: -21.1, 64.3]; OR, 1.6 [95% CI: 0.6, 4.5]). Conclusion DBT plus SM screening appears to lead to higher detection of early-stage invasive breast cancers of grade 2 or 3 than DM screening, with the highest rate among women aged 60-70 years with dense breasts. Clinical trial registration no. NCT03377036 © RSNA, 2023 See also the editorial by Ha and Chang in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Weigel S, Heindel W, Decker T, et al. Digital Breast Tomosynthesis versus Digital Mammography for Detection of Early-Stage Cancers Stratified by Grade: A TOSYMA Subanalysis. Radiology. 2023. PMID: 38051184. doi:10.1148/radiol.231533

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。